SWOT Analysis for Suven Life Sciences Ltd. - Opportunity

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Year

Companies with no Debt

Consistent high performing stocks over Five Years

PEG lower than Industry PEG

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

Promoter holding decreased by more than -2% QoQ

Negative profit growth, promoters decreasing shareholding QoQ

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Degrowth in Revenue and Profit

Declining profits every quarter for the past 3 quarters

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Fall in Quarterly Revenue and Net Profit (YoY)

Weak Momentum: Price below Short, Medium and Long Term Averages

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

Stocks Underperforming their Industry Price Change in the Quarter

Buys by Superstar Investors

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Decline in Net Profit with falling Profit Margin (QoQ)